Supplementary
No significant differences were found between the escitalopram and placebo groups; and no significant differences were found between those followed-up and exited after baseline evaluation except for the Killip class (p=0.019) and serum CK-MB level (p=0.022)* using t-tests, χ 2 tests, or Fisher's exact tests, as appropriate. EsDEPACS: Escitalopram for DEPression in Acute Coronary Syndrome study, HAMD: Hamilton Depression Rating Scale, ACS: acute coronary syndrome, LVEF: left ventricular ejection fraction, CK-MB: creatine kinase-MB
